Publisher: Springer Publishing
Year of Publication: 2012
Author(s) : Bryan Brooks and Duane Huggett
Human interaction with the environment remains one of the most pervasive facets of modern society. In a world characterized by rapid population growth, unprecedented global trade and digital communications, energy security, natural resource scarcities, climatic changes and environmental quality, emerging diseases and public health, biodiversity and habitat modifications are routinely touted by the popular press as they canvas global political agendas and scholarly endeavours.
Drugs found in drinking water. India’s drug problem. Chances are you’ve seen these headlines. Human pharmaceuticals represent environmental contaminants of emerging concern, and receive unprecedented attention from the scientific, regulatory and public sectors. This timely contribution, prepared by international experts in the field, synthesizes and critically examines topics ranging from regulations, environmental chemistry and exposure analysis, to comparative pharmacology, environmental toxicology, water treatment technologies and pharmaceutical take back programs. Compared to historical contaminants, chemical and biological attributes of human pharmaceuticals present unique challenges to environmental management, but lessons learned from the study of pharmaceuticals promise to advance prospective and retrospective approaches to assess the impacts of industrial chemicals. Students and environmental scientists, managers, regulators, and public health professionals will benefit from this forward-thinking treatment of human pharmaceuticals in the environment.